Clarivate Heads Into Q3 Print With Bears Still in Control

CLVT enters its October 29 Q3 results with short sellers firmly dug in and options traders leaning bullish, a split that makes the positioning story more interesting than the stock's modest recent recovery.

Short interest runs at 7.1% of the free float, roughly 46.9 million shares, and has eased about 3.2% over the past week. The direction is right for the bulls, but the level remains elevated. Borrow costs have dropped sharply, down around 25% on the week to 0.50%, and availability has loosened considerably to 82.5%, up from below 50% for much of October. That combination, falling shorts plus easier borrow conditions, suggests some bears are reducing exposure ahead of the print rather than pressing the trade. The ORTEX short score nevertheless holds at 75.4, ranking in the 98th percentile of the universe, so the aggregate bearish signal has not yet dissipated. Options traders are telling a different story: the put/call ratio has dropped to 0.08, well below its 20-day average of 0.10 and close to its 52-week low of 0.03. That is unusually call-heavy positioning, implying demand for upside exposure rather than downside protection into the release.

The analyst community has been uniformly cautious since the last print. After Q2 results on July 29, the stock fell 16% in a single session and extended to a 19% loss over the following five days. Every major firm that followed up cut its target. Goldman Sachs and Citigroup maintained Neutral ratings while trimming to $2.60 and $2.50 respectively. Barclays stayed at Underweight with a $2.00 target. Stifel kept its Buy but cut from $6.00 to $5.00. None of those moves are recent enough to reflect fresh fundamental views, and the gap between Stifel's $5.00 target and the current price of $1.87 looks wide enough to warrant caution about reading consensus as directionally meaningful. The broader debate pits a company priced for near-terminal distress against a business that still generates cash and trades at just 5.9x EV/EBITDA. The EPS forward momentum rank sits in the 90th percentile, driven by a low base, but the EPS surprise rank is near the bottom of the universe at the 4th percentile, meaning the company has repeatedly missed even reset expectations.

The ownership picture adds another layer. Impactive Capital, an activist manager, is on the Schedule 13D register with a 3.5% stake filed in February 2026. An activist on the register is one of the more newsworthy facts about the stock: it raises the possibility of structural pressure on management even if the position itself is below the 5% disclosure threshold. As a caveat, 13D/G disclosures are event-driven around that threshold, and Impactive's actual current stake may differ from the February filing. BlackRock added over 10 million shares in the quarter to September 30, bringing its holding to roughly 4.9% of shares. Cambridge Information Group trimmed by about 2.5 million shares over the same period. Clarkston Capital Partners added nearly 2.9 million to hold 7.1%. The institutional base is actively repositioning, which tends to amplify post-earnings moves in a low-priced, heavily shorted name.

History provides a sobering reference point: the last print produced one of the sharpest single-day declines in the peer group. The October 29 release will test whether the company can show enough stabilisation in its revenue trajectory to challenge the bearish consensus that has built since the summer, or whether the pattern of estimate misses continues despite a reset bar.